2021      |      2020      |      2019      |      2018      |      2017
Key events in 2020

 

Date Event Title Add to Calendar
14 Dec Closing of the acquisition of Deep Longevity, Inc N/A
14 Dec Announcement on the marketing authorisation approval granted to Orient EuroPharma Co., Ltd. from the Taiwan Food and Drug Administration in respect of Fortacin™ N/A
09 Dec Extraordinary General Meeting
02 Dec Announcement on the approval granted to Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. from the National Medical Products Administration of China to submit the investigational new drug application in respect of Senstend™ for human clinical trial of a Licensed Product N/A
02 Sep Two share purchase agreements entered into with various sellers in respect of the acquisition of Deep Longevity, Inc., subject to the shareholders' approval to be sought at an extraordinary general meeting for a specific mandate for the issue and allotment of the consideration shares N/A
27 Aug Approval received from the European Commission for the switch of the marketing authorisation for Foratin™ to "Over-the-Counter" status from prescription N/A
24 Aug 2020 Interim Results Announcement N/A
17 Jun 2020 Annual General Meeting
31 Mar
(As revised)
2019 Annual Results Announcement N/A